{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:43:58Z","timestamp":1793519038253,"version":"4.5.0"},"reference-count":68,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The recurrence of malignancy after hematopoietic cell transplantation (HCT) is the primary cause of transplantation failure. The NKG2D axis is a powerful pathway for antitumor responses, but its role in the control of malignancy after HCT is not well-defined. We tested the hypothesis that gene variation of the NKG2D receptor and its ligands MICA and MICB affect relapse and survival in 1629 patients who received a haploidentical HCT for the treatment of a malignant blood disorder. Patients and donors were characterized for MICA residue 129, the exon 5 short tandem repeat (STR), and MICB residues 52, 57, 98, and 189. Donors were additionally defined for the presence of NKG2D residue 72. Mortality was higher in patients with MICB-52Asn relative to those with 52Asp (hazard ratio [HR], 1.83; 95% confidence interval [CI], 1.24-2.71; P\u00a0= .002) and lower in those with MICA-STR mismatch than in those with STR match (HR, 0.66; 95%\u00a0CI, 0.54-0.79; P\u00a0= .00002). Relapse was lower with NKG2D-72Thr donors than with 72Ala donors (relapse HR, 0.57; 95%\u00a0CI, 0.35-0.91; P\u00a0= .02). The protective effects of patient MICB-52Asp with donor MICA-STR mismatch and NKG2D-72Thr were enhanced when all 3 features were present. The NKG2D ligand\/receptor pathway is a transplantation determinant. The immunobiology of relapse is defined by the concerted effects of MICA, MICB, and NKG2D germ line variation. Consideration of NKG2D ligand\/receptor pairings may improve survival for future patients.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008922","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T15:24:33Z","timestamp":1676042673000},"page":"2888-2896","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-3683","authenticated-orcid":false,"given":"Effie W.","family":"Petersdorf","sequence":"first","affiliation":[{"name":"1Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2161-8259","authenticated-orcid":false,"given":"Caroline","family":"McKallor","sequence":"additional","affiliation":[{"name":"1Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Malkki","sequence":"additional","affiliation":[{"name":"1Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilun","family":"He","sequence":"additional","affiliation":[{"name":"3National Marrow Donor Program\/BeTheMatch, Center for International Blood and Marrow Transplant Research, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[{"name":"3National Marrow Donor Program\/BeTheMatch, Center for International Blood and Marrow Transplant Research, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine C.","family":"Hsu","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland K.","family":"Strong","sequence":"additional","affiliation":[{"name":"5Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[{"name":"1Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Stevenson","sequence":"additional","affiliation":[{"name":"1Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"5562","key":"2023062614232620400_bib1","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"7","key":"2023062614232620400_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol"},{"issue":"8","key":"2023062614232620400_bib3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbmt.2006.04.008","article-title":"KIR ligands and prediction of relapse after unrelated donor hematooietic cell transplantation for hematologic malignancy","volume":"12","author":"Hsu","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2023062614232620400_bib4","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.4049\/jimmunol.1302517","article-title":"Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia","volume":"192","author":"Cooley","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"2023062614232620400_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","article-title":"Receptors for HLA class-I molecules in human natural killer cells","volume":"14","author":"Moretta","year":"1996","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2023062614232620400_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2023062614232620400_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"14","key":"2023062614232620400_bib8","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.91.14.6259","article-title":"A\u00a0second lineage of mammalian major histocompatibility complex class I genes","volume":"91","author":"Bahram","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5428","key":"2023062614232620400_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"issue":"4","key":"2023062614232620400_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s002510100325","article-title":"Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family","volume":"53","author":"Steinle","year":"2001","journal-title":"Immunogenetics"},{"issue":"6908","key":"2023062614232620400_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"issue":"10","key":"2023062614232620400_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nri1199","article-title":"Roles of the NKG2D immunoreceptor and its ligands","volume":"3","author":"Raulet","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2023062614232620400_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ni929","article-title":"NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway","volume":"4","author":"Billadeau","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"2023062614232620400_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2010.00893.x","article-title":"Effect of NKG2D ligand expression on host immune responses","volume":"235","author":"Champsaur","year":"2010","journal-title":"Immunol Rev"},{"key":"2023062614232620400_bib15","unstructured":"IPD-IMGT\/HLA database release 3.48.0 (2022-04) version report - build 207cdce. Accessed 25 April 2022. https:\/\/www.ebi.ac.uk\/ipd\/imgt\/hla\/."},{"issue":"D1","key":"2023062614232620400_bib16","first-page":"D948","article-title":"IPD-IMGT\/HLA database","volume":"48","author":"Robinson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2023062614232620400_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2020.00314","article-title":"High-throughput MICA\/B genotyping of over two million samples: workflow and allele frequencies","volume":"11","author":"Klussmeier","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"2023062614232620400_bib18","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1073\/pnas.94.4.1298","article-title":"Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease","volume":"94","author":"Mizuki","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2023062614232620400_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1399-0039.1997.tb02778.x","article-title":"Trinucleotide repeat polymorphism within exon 5 of MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian","volume":"49","author":"Ota","year":"1997","journal-title":"Tissue Antigens"},{"issue":"5","key":"2023062614232620400_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02602779","article-title":"Allelic repertoire of the human MHC class I MICA gene","volume":"44","author":"Fodil","year":"1996","journal-title":"Immunogenetics"},{"issue":"2","key":"2023062614232620400_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","article-title":"Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA\u2217008 that is shed by tumor cells in exosomes","volume":"70","author":"Ashiru","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"2023062614232620400_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/BJ20130194","article-title":"A\u00a0GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA\u2217008","volume":"454","author":"Ashiru","year":"2013","journal-title":"Biochem J"},{"issue":"2","key":"2023062614232620400_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00251-015-0884-8","article-title":"The MICA-129Met\/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA","volume":"68","author":"Isernhagen","year":"2016","journal-title":"Immunogenetics"},{"issue":"14","key":"2023062614232620400_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-5890(02)00032-9","article-title":"Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer","volume":"38","author":"Strong","year":"2002","journal-title":"Mol Immunol"},{"issue":"3","key":"2023062614232620400_bib25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.169.3.1395","article-title":"Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D","volume":"169","author":"Holmes","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"6509","key":"2023062614232620400_bib26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"GTEx Consortium","year":"2020","journal-title":"Science"},{"issue":"5","key":"2023062614232620400_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/87757","article-title":"Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA","volume":"2","author":"Li","year":"2001","journal-title":"Nat Immunol"},{"issue":"3","key":"2023062614232620400_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.humimm.2006.02.012","article-title":"MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome","volume":"67","author":"Kitcharoen","year":"2006","journal-title":"Hum Immunol"},{"issue":"21","key":"2023062614232620400_bib29","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1182\/blood-2009-08-239301","article-title":"Limited role of MHC class I chain-related genes A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation","volume":"114","author":"Anderson","year":"2009","journal-title":"Blood"},{"issue":"25","key":"2023062614232620400_bib30","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1182\/blood-2009-04-217430","article-title":"MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease","volume":"114","author":"Boukouaci","year":"2009","journal-title":"Blood"},{"issue":"14","key":"2023062614232620400_bib31","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1182\/blood-2009-05-223172","article-title":"Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease","volume":"114","author":"Parmar","year":"2009","journal-title":"Blood"},{"issue":"11","key":"2023062614232620400_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.15252\/emmm.201505246","article-title":"The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation","volume":"7","author":"Isernhagen","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"15","key":"2023062614232620400_bib33","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2016-05-719070","article-title":"Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD","volume":"128","author":"Carapito","year":"2016","journal-title":"Blood"},{"issue":"26","key":"2023062614232620400_bib34","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2016-05-716357","article-title":"Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation","volume":"128","author":"Fuerst","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2023062614232620400_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbmt.2016.11.021","article-title":"MHC class I chain-related gene A (MICA) donor-recipient mismatches and MICA-129 polymorphism in unrelated donor hematopoietic cell transplantations has no impact on outcomes in acute lymphoblastic leukemia, acute myeloid leukemia, or myelodysplastic syndrome: a Center for International Blood and Marrow Transplant Research study","volume":"23","author":"Askar","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"2023062614232620400_bib36","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/bloodadvances.2020001927","article-title":"Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation","volume":"4","author":"Martin","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"2023062614232620400_bib37","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41409-020-0886-5","article-title":"Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status","volume":"55","author":"Carapito","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"2023062614232620400_bib38","first-page":"4636","article-title":"Single-nucleotide polymorphisms in MICA and MICB genes could play a role in the outcome of AML patients after HSCT","volume":"10","author":"Machuldova","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"10","key":"2023062614232620400_bib39","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3324\/haematol.2009.008318","article-title":"NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies","volume":"94","author":"Espinoza","year":"2009","journal-title":"Haematologica"},{"issue":"17","key":"2023062614232620400_bib40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2023062614232620400_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"2023062614232620400_bib42","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1182\/bloodadvances.2020003110","article-title":"Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide","volume":"4","author":"Solomon","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"2023062614232620400_bib43","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2023062614232620400_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023062614232620400_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2023062614232620400_bib46","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol"},{"key":"2023062614232620400_bib47","unstructured":"National Library of Medicine. NCBI variation viewer. Accessed 1 February 2022. https:\/\/www.ncbi.nlm.nih.gov\/variation\/view."},{"key":"2023062614232620400_bib48","doi-asserted-by":"crossref","first-page":"742881","DOI":"10.3389\/fimmu.2021.742881","article-title":"MHC Variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals","volume":"12","author":"Castelli","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2023062614232620400_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/infdis\/jiaa134","article-title":"Major histocompatibility complex class I chain-related A and B (MICA and MICB) gene, allele, and haplotype associations with dengue infections in ethnic Thais","volume":"222","author":"Luangtrakool","year":"2020","journal-title":"J Infect Dis"},{"issue":"6","key":"2023062614232620400_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1503\/jpn.150210","article-title":"Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population","volume":"41","author":"Yin","year":"2016","journal-title":"J\u00a0Psychiatry Neurosci"},{"issue":"8","key":"2023062614232620400_bib51","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"2023062614232620400_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/sji.12072","article-title":"Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications","volume":"78","author":"Chitadze","year":"2013","journal-title":"Scand J Immunol"},{"issue":"12","key":"2023062614232620400_bib53","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2023062614232620400_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/iji.12527","article-title":"BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation","volume":"48","author":"Little","year":"2021","journal-title":"Int J Immunogenet"},{"key":"2023062614232620400_bib55","unstructured":"Research CIBMTR\n          . The US summary slides - HCT trends and survival data 2021. Accessed 6 July 2022. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx."},{"issue":"24","key":"2023062614232620400_bib56","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.2017.77.6534","article-title":"Patient HLA germline variation and transplant survivorship","volume":"36","author":"Petersdorf","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"2023062614232620400_bib57","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood.2022015860","article-title":"HLA-DQ heterodimers in hematopoietic cell transplantation","volume":"139","author":"Petersdorf","year":"2022","journal-title":"Blood"},{"issue":"6","key":"2023062614232620400_bib58","doi-asserted-by":"crossref","first-page":"e0217868","DOI":"10.1371\/journal.pone.0217868","article-title":"Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study","volume":"14","author":"Onyeaghala","year":"2019","journal-title":"PLoS One"},{"key":"2023062614232620400_bib59","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2017.00368","article-title":"Natural killer group 2, member D\/NKG2D ligands in hematopoietic cell transplantation","volume":"8","author":"Carapito","year":"2017","journal-title":"Front Immunol"},{"issue":"24","key":"2023062614232620400_bib60","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1074\/jbc.M808561200","article-title":"The traffic of the NKG2D\/Dap10 receptor complex during natural killer (NK) cell activation","volume":"284","author":"Roda-Navarro","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"2023062614232620400_bib61","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3389\/fimmu.2018.00926","article-title":"MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"issue":"6383","key":"2023062614232620400_bib62","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"issue":"5","key":"2023062614232620400_bib63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41591-022-01725-2","article-title":"The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation","volume":"28","author":"Carapito","year":"2022","journal-title":"Nat Med"},{"key":"2023062614232620400_bib64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fimmu.2012.00299","article-title":"Human NKG2D-ligands: cell biology strategies to ensure immune recognition","volume":"3","author":"Fernandez-Messina","year":"2012","journal-title":"Front Immunol"},{"issue":"9","key":"2023062614232620400_bib65","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.2741\/2939","article-title":"Soluble NKG2D ligands: prevalence, relapse, and functional impact","volume":"13","author":"Salih","year":"2008","journal-title":"Front Biosci"},{"issue":"7","key":"2023062614232620400_bib66","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V81.7.1923.1923","article-title":"The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation","volume":"81","author":"Petersdorf","year":"1993","journal-title":"Blood"},{"issue":"7","key":"2023062614232620400_bib67","doi-asserted-by":"crossref","first-page":"357.e1","DOI":"10.1016\/j.jtct.2022.03.026","article-title":"Race and survival in unrelated hematopoietic cell transplantation","volume":"28","author":"Morishima","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2023062614232620400_bib68","doi-asserted-by":"crossref","first-page":"713158","DOI":"10.3389\/fimmu.2021.713158","article-title":"Leveraging NKG2D ligands in immune-oncology","volume":"12","author":"Fuertes","year":"2021","journal-title":"Front Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/12\/2888\/2060032\/blooda_adv-2022-008922-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/12\/2888\/2060032\/blooda_adv-2022-008922-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:25:54Z","timestamp":1687775154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/12\/2888\/494411\/Role-of-NKG2D-ligands-and-receptor-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,6,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008922","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}